elranatamab
pfizer
['multiplemyeloma', 'magnetismm-3', 'mmsm', 'elranatamab', 'pf-06863135']
nct04649359: phase 2 - magnetismm-3: elranatamab (pf-06863135) monotherapy in relapsed #multiplemyeloma #mmsm #asco22 
Multiple Myeloma Education Platform for Myeloma Community